Medical Developments International Ltd. engages in the manufacture and distribution of pharmaceutical drugs, medical, and veterinary equipment. The firm operates in two segments: Pain Management and Respiratory. The Pain Management segment is engaged in the supply of analgesia for acute and procedural pain. The firm manufactures inhaled analgesic, Penthrox (the Green Whistle), at manufacturing facilities at Scoresby and Springvale in Victoria, Australia. Penthrox is sold into domestic and international markets through distribution partnerships and direct in-market capability. The Respiratory segment is a supplier of respiratory products including asthma and chronic obstructive pulmonary disease (COPD) space chambers, peak flow meters, portable nebulizers and silicone face masks. Respiratory supplies into Australia, the United States of America, Europe, and Asia through partnerships with distributors.
Follow-Up Questions
MDDVF 주식의 가격 성능은 어떻습니까?
MDDVF의 현재 가격은 $0이며, 전 거래일에 decreased 0% 하였습니다.
Medical Developments International Ltd의 주요 사업 주제나 업종은 무엇입니까?
Medical Developments International Ltd은 Pharmaceuticals 업종에 속하며, 해당 부문은 Health Care입니다
Medical Developments International Ltd의 시가총액은 얼마입니까?
Medical Developments International Ltd의 현재 시가총액은 $0입니다
Medical Developments International Ltd는 매수, 매도, 아니면 보유해야 하나요?
월스트리트 분석가들에 따르면, 3명의 분석가가 Medical Developments International Ltd에 대한 분석 평가를 실시했으며, 이는 1명의 강력한 매수, 3명의 매수, 1명의 보유, 0명의 매도, 그리고 1명의 강력한 매도를 포함합니다